PMC9818680_01
Photo demonstrating the clinical efficacy of 3-month adalimumab therapy on periodontitis; before treatment (left image) and after treatment (right image). Visible changes: (1) reduced inflammation of upper gingiva, particularly evident as less purplish coloration adjacently to the upper canine tooth, (2) reduction of desquamation of mucosal surface in upper and lower gingiva exemplified by restoration of natural shiny mucosa with post-inflammatory hyperpigmented spots instead of superficial ulcerations, and (3) considerable pan-oral reduction in dental plaque formation.
cde-2023-0015-0001-528139_f1.jpg
PMC9818680_01_cde-2023-0015-0001-528139_f1.jpg
F1
When evaluated at our department, she experienced gradual relapse of HS and was also diagnosed with periodontitis, reporting severe gingival irritation and bleeding in relation to dental care, i.e., tooth brushing and dental flossing as shown in Figure 1 (left image). A comparison of the images before and after adalimumab treatment of the patient's teeth revealed fewer dental plaques, less discoloration, and reduced gingival inflammation as shown in Figure 1 (right panel).